Results 141 to 150 of about 29,557,581 (269)
Report Cost Consequence Analysis
Task 5.3 Analyse cost and effect data and produce cost consequence analysis (M34-M39)All partners involved in the clinical WP2 study will receive the cost consequence balance sheet developed in task 5.1 to fill in their real cost associated with Palliative Care Sedation intervention.
openaire +1 more source
Digital Cognitive Phenotyping for Differential Diagnosis and Monitoring in Neurological Conditions
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To assess the utility, accessibility, and equivalence to supervised scales of online cognitive assessment in older individuals with cognitive impairment. Methods Patients with Alzheimer's disease (AD, n = 31), idiopathic normal pressure hydrocephalus (iNPH, n = 26), and traumatic brain injury (TBI, n = 23) completed online cognitive ...
Martina Del Giovane +10 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand +5 more
wiley +1 more source
Failure Mode And Effects Analysis As A Mechanism For Assessing The Cost Consequence Of A Failure
, 2015 This study investigated the possibility of including the cost consequence of a failure in the a priori risk assessment methodology known as Failure Modes and Effects Analysis (FMEA).
Guinot, Jeffrey
core
Cost-effectiveness plane: Cost-utility analysis with life-time horizon.
Cost-effectiveness plane: Cost-utility analysis with life-time horizon.
Dyfrig Hughes (40543) +5 more
core +1 more source
PNS223 A BIBLIOMETRICS ANALYSIS OF COST-CONSEQUENCE ANALYSIS USED IN ECONOMICAL EVALUATIONS [PDF]
Value in Health, 2019 G. Xin, G. Zhang, D. Malone, W. Tang
openaire +1 more source
Bi‐ and Mono‐Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective RFC1 biallelic repeat expansion is increasingly recognized as a cause of chronic idiopathic axonal polyneuropathy (CIAP), but it remains challenging to know who to test. This study aims to determine the prevalence of biallelic and monoallelic RFC1 expansions and their corresponding neuropathy phenotypes in CIAP patients and identify ...
Amro M. Stino +25 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau +11 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch +5 more
wiley +1 more source
PST4 COST-CONSEQUENCE ANALYSIS FOR THE HANDMASTER IN THE NETHERLANDS
Value in Health, 2005 Nuijten, MJ, Engelfriet, P
openaire +1 more source